Characterization of cytolytic T lymphocyte (CTL) responses to tumor antigens has been impeded by a lack of direct assays of CTL activity. We have synthesized reagents (“tetramers”) that specifically stain CTLs recognizing melanoma antigens. Tetramer staining of tumor-infiltrated lymph nodes ex vivo revealed high frequencies of tumor-specific CTLs which were antigen-experienced by surface phenotype. In vitro culture of lymph node cells with cytokines resulted in very large expansions of tumor-specific CTLs that were dependent on the presence of tumor cells in the lymph nodes. Tetramer-guided sorting by flow cytometer allowed isolation of melanoma-specific CTLs and confirmation of their specificity and their ability to lyse autologous tumor cells. Our results demonstrate the value of these novel reagents for monitoring tumor-specific CTL responses and for generating CTLs for adoptive immunotherapy. These data also indicate that strong CTL responses to melanoma often occur in vivo, and that the reactive CTLs have substantial proliferative and tumoricidal potential.
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes
Address correspondence to Pedro Romero, Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire Vaudois - BH 19-602, 1011 Lausanne, Switzerland. Phone: 41-21-314-01-78; Fax: 41-21-314-74-77; E-mail: [email protected]
This work is partly funded by the United Kingdom Medical Research Council and Cancer Research Campaign. P.R. Dunbar is the Girdlers Research Fellow at Green College.
P. Romero and P.R. Dunbar contributed equally to this work.
Pedro Romero, P. Rod Dunbar, Danila Valmori, Mikaël Pittet, Graham S. Ogg, Donata Rimoldi, Ji-Li Chen, Danielle Liénard, Jean-Charles Cerottini, Vincenzo Cerundolo; Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes . J Exp Med 2 November 1998; 188 (9): 1641–1650. doi: https://doi.org/10.1084/jem.188.9.1641
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement